| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA599766
Max Phase: Preclinical
Molecular Formula: C12H13N5O4
Molecular Weight: 291.27
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1cc2cn([C@H]3C[C@H](N=[N+]=[N-])[C@@H](CO)O3)c(=O)nc2o1
Standard InChI: InChI=1S/C12H13N5O4/c1-6-2-7-4-17(12(19)14-11(7)20-6)10-3-8(15-16-13)9(5-18)21-10/h2,4,8-10,18H,3,5H2,1H3/t8-,9+,10+/m0/s1
Standard InChI Key: ZODKCZVROAFPFE-IVZWLZJFSA-N
Associated Targets(non-human)
Deoxynucleoside kinase 95 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 291.27 | Molecular Weight (Monoisotopic): 291.0968 | AlogP: 1.26 | #Rotatable Bonds: 3 |
| Polar Surface Area: 126.25 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: | CX LogP: 0.06 | CX LogD: -0.05 |
| Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.52 | Np Likeness Score: 0.82 |
References
| 1. Li Y, Soni PB, Liu L, Zhang X, Liotta DC, Lutz S.. (2010) Synthesis of fluorescent nucleoside analogs as probes for 2'-deoxyribonucleoside kinases., 20 (3): [PMID:20060716] [10.1016/j.bmcl.2009.12.097] |
Source
Source(1):